INSM Stock Analysis: Buy, Sell, or Hold?
INSM - Insmed, Inc.
$98.60
-2.89 (-2.85%)
▼
5d:
-7.78%
30d:
-7.85%
90d:
-27.68%
HOLD
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
3d
Smart Money Accumulation
None View Scanner →
Strength: 7.7/10
Get Alerted When INSM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: INSM trades at premium valuation expecting 39.1% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: INSM trades at premium valuation expecting 39.1% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: INSM is currently trading at $98.60, which is considered oversold relative to its 30-day fair value range of $102.51 to $112.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 768.5) compared to its historical average (285.3). At these levels, the market is pricing in 39.1% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, INSM is in a strong downtrend. The price is currently testing key support at $97.05. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $196.18 (+99.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INSM is in a strong downtrend. The price is currently testing key support at $97.05. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $196.18 (+99.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$102.51 -
$112.00
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding INSM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 99.0% below Wall St target ($196.18)
- BEARISH: Market expects 39.1% growth - appears too optimistic based on history
- CAUTION: Recommendation downgraded due to -7.8% 5-day decline
Trading Range Analysis
30-Day Trading Range
$102.51 -
$112.00
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$97.05
Resistance Level
$109.99
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
768.51
Wall Street Target
$196.18
(+99.0%)
Revenue Growth (YoY)
229.6%
Profit Margin
-144.4%
Valuation Premium vs History
+39.1% premium
PE vs Historical
768.5 vs 285.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+39.1%
(market-implied from PE analysis)
1-Year Target
$137.15
(+39%)
2-Year Target
$190.78
(+94%)
3-Year Target
$265.37
(+169%)
3-Yr Target (if PE normalizes)
(PE: 769→285)
PE COMPRESSION
$98.52
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 02, 2026 5:15 PM ET
Data refreshes hourly during market hours. Next update: 6:15 PM
Data refreshes hourly during market hours. Next update: 6:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INSM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
William Lewis
SELL
10699 shares
2026-04-16
William Lewis
SELL
10699 shares
2026-04-06
Roger Adsett
SELL
88060 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 58 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$127 | 59 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 56 HOLD |
Advanced INSM Option Strategies
Professional options setups generated by AI based on today's INSM price and gamma walls.
